X
20
Astellas Pharma Inc. Tokyo Jp, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Tamsulosin hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2007-253 - Rev 04
This Chemical Type CEP, issued on May 11, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2131 associated with this CEP further emphasizes